Cargando…
Oral melphalan as a treatment for platinum-resistant ovarian cancer
A large number of drugs have been used to treat recurrent ovarian cancer, yet there are few data that guide the physician's choice. Typically, the decision to re-treat with platinum-based therapy depends on the progression-free interval. However, the optimum agent for the treatment of platinum-...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741128/ https://www.ncbi.nlm.nih.gov/pubmed/12799622 http://dx.doi.org/10.1038/sj.bjc.6601044 |